Tsiantoulas, Dimitrios http://orcid.org/0000-0002-7743-3192
Eslami, Mahya
Obermayer, Georg
Clement, Marc
Smeets, Diede
Mayer, Florian J.
Kiss, Máté G. http://orcid.org/0000-0002-9215-8328
Enders, Lennart http://orcid.org/0000-0001-8341-3350
Weißer, Juliane
Göderle, Laura http://orcid.org/0000-0003-1037-3137
Lambert, Jordi
Frommlet, Florian
Mueller, André
Hendrikx, Tim
Ozsvar-Kozma, Maria
Porsch, Florentina http://orcid.org/0000-0002-2633-6632
Willen, Laure
Afonyushkin, Taras
Murphy, Jane E. http://orcid.org/0000-0003-2201-9469
Fogelstrand, Per
Donzé, Olivier
Pasterkamp, Gerard
Hoke, Matthias
Kubicek, Stefan http://orcid.org/0000-0003-0855-8343
Jørgensen, Helle F. http://orcid.org/0000-0002-7909-2977
Danchin, Nicolas
Simon, Tabassome
Scharnagl, Hubert
März, Winfried
Borén, Jan http://orcid.org/0000-0003-0786-8091
Hess, Henry
Mallat, Ziad http://orcid.org/0000-0003-0443-7878
Schneider, Pascal http://orcid.org/0000-0003-0677-9409
Binder, Christoph J. http://orcid.org/0000-0001-8313-7050
Article History
Received: 14 June 2019
Accepted: 12 July 2021
First Online: 25 August 2021
Competing interests
: D.T., C.J.B., P.S. and M.E. are named inventors on a patent application (EP20217536.0; pending) to exploit c-APRIL and nc-APRIL for diagnostic and therapeutic purposes in cardiovascular disease that has been filed by the Medical University of Vienna (Austria) and CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (Austria). O.D. is an employee of Adipogen Life Sciences, which provided some reagents used in this study.